Deciphering mechanisms of Listeria placental-fetal invasion

破译李斯特菌胎盘-胎儿侵袭机制

基本信息

项目摘要

Project Summary Listeria monocytogenes (Lm) is a facultative gram-positive intracellular bacterium that causes infection in humans via ingestion of contaminated food. Severe infection can occur in elderly and immunocompromised patients well as in pregnant women and neonates. Infection can lead to meningitis, meningoencephalitis, brain abscess, and, for pregnant women, abortion, still-birth, and disseminated fetal infection. The high mortality rate of invasive Lm disease despite antibiotic treatment highlights the need for new effective therapeutic strategies for managing Lm infections. Previous studies have shown that distinct isolates of Lm can exhibit different tissue tropisms, resulting in the acquisition of novel target organ replication niches. A clinical Lm isolate, 07PF0776, was found to have an enhanced ability to target cardiac tissue based on amino acid variations present within InlB, a bacterial surface protein associated with host cell invasion. These amino acid variations appear to increase stability and promote binding to host surface heparin sulfate moieties, which results in recruitment of InlB to the host cell surface and stimulation of Met, the receptor bound by InlB. The Met receptor is abundantly expressed by placental tissue and is required for embryonic and placental development. Preliminary data has shown at least two Lm cardiotropic strains expressing the InlB variant exhibit significantly enhanced vertical transmission. We hypothesize that modification of InlB can expand the tissue repertoire of Lm and enhance invasion through the manipulation of Met signaling pathways, leading to increased rates of fetal transmission. The specific aims of this proposal will undertake a functional assessment of Lm InlB variant strains to examine their efficacy of vertical transmission as well as determine the mechanisms by which overexpression and/or increased stability of InlB increases vertical transmission. Aim 1 will undertake a functional assessment of cardiotropic strains for efficiency of vertical transmission to define and identify strains of Lm that pose an enhanced risk for fetal disease. Aim 2 will determine the mechanisms by which overexpression of InlB increases Lm vertical transmission. These studies will thus clarify how select Lm isolates gain access with high efficiency to placental/fetal tissues to cause devastating forms of neonatal disease and death.
项目摘要 单核细胞增生李斯特菌(LM)是一种兼性革兰氏阳性细胞内细菌,导致 通过摄入受污染的食物而在人类中感染。老年人可能发生严重的感染 免疫功能低下的患者和孕妇和新生儿一样。感染会导致 脑膜炎,脑膜脑炎,脑脓肿,以及孕妇,流产,仍然出生和 传播胎儿感染。尽管抗生素,但侵入性LM疾病的死亡率很高 治疗强调了需要新的有效治疗策略来管理LM感染。 先前的研究表明,不同的LM分离株可以表现出不同的组织偏见,从而 在获取新型目标器官复制壁ni。发现临床LM分离株,07pf0776 根据存在的氨基酸变化,具有增强的靶向心脏组织的能力 INLB,一种与宿主细胞浸润有关的细菌表面蛋白。这些氨基酸的变化 似乎增加了稳定性并促进与宿主表面硫酸肝素部分的结合,该部分 结果导致INLB募集到宿主细胞表面并刺激MET,受体约束 inlb。 MET受体通过胎盘组织大量表达,并且需要胚胎和 胎盘发展。初步数据至少显示了表达的两个LM心脏菌株 INLB变体显示出显着增强的垂直传输。我们假设修改 INLB可以扩大LM的组织库,并通过操纵MET增强侵袭 信号通路,导致胎儿传播速率增加。该提议的具体目的 将对LM INLB变体菌株进行功能评估,以检查其垂直的功效 传输以及确定过表达和/或增加稳定性的机制 INLB的垂直传输增加。 AIM 1将对心脏的功能评估进行功能评估 垂直传输效率的应变,以定义和识别构成LM的菌株 增加了胎儿疾病的风险。 AIM 2将确定过表达的机制 INLB增加了LM垂直传输。因此,这些研究将阐明选择的LM分离株如何获得 效率高的胎盘/胎儿组织访问会引起毁灭性的新生儿疾病形式 和死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Nancy Elizabeth Fr...的其他基金

Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
  • 批准号:
    10363099
    10363099
  • 财政年份:
    2022
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
  • 批准号:
    10646152
    10646152
  • 财政年份:
    2022
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
解读镇​​静剂选择对肺炎克雷伯菌肺部感染动态的影响
  • 批准号:
    10350966
    10350966
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
解读镇​​静剂选择对肺炎克雷伯菌肺部感染动态的影响
  • 批准号:
    10527379
    10527379
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
  • 批准号:
    10436619
    10436619
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering how bacterial pheromone signaling enhances Listeria virulence
破译细菌信息素信号如何增强李斯特菌毒力
  • 批准号:
    8806236
    8806236
  • 财政年份:
    2014
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering how bacterial pheromone signaling enhances Listeria virulence
破译细菌信息素信号如何增强李斯特菌毒力
  • 批准号:
    8965502
    8965502
  • 财政年份:
    2014
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
21st Annual Midwest Microbial Pathogenesis Conference
第21届年度中西部微生物发病机制会议
  • 批准号:
    8785218
    8785218
  • 财政年份:
    2014
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering how anesthetics increase host susceptibility to microbial infection
破译麻醉剂如何增加宿主对微生物感染的易感性
  • 批准号:
    8462202
    8462202
  • 财政年份:
    2012
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Deciphering how anesthetics increase host susceptibility to microbial infection
破译麻醉剂如何增加宿主对微生物感染的易感性
  • 批准号:
    8383227
    8383227
  • 财政年份:
    2012
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:

相似海外基金

ARRAY: A novel polymeric mesh for prophylactic antibiotic protection of cardiac implantable electronic devices
ARRAY:一种新型聚合物网,用于心脏植入电子设备的预防性抗生素保护
  • 批准号:
    10600803
    10600803
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Impact of hyperglycemia on the pathogenesis of chronic bacterial lung infection
高血糖对慢性细菌性肺部感染发病机制的影响
  • 批准号:
    10741890
    10741890
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
  • 批准号:
    10674131
    10674131
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Polyamine Dysregulation in the Gastric Epithelium during Helicobacter pylori Infection and its Impact on Gastric Carcinogenesis
幽门螺杆菌感染期间胃上皮多胺失调及其对胃癌发生的影响
  • 批准号:
    10604957
    10604957
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别:
Mechanisms and In Vivo Activity of a Next Generation Daptomycin Antibiotic
下一代达托霉素抗生素的机制和体内活性
  • 批准号:
    10593558
    10593558
  • 财政年份:
    2022
  • 资助金额:
    $ 23.99万
    $ 23.99万
  • 项目类别: